Trade KALA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
KALA BIO, Inc. (KALA) is trading at US$0.54, down 4.53% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$15.86M. Over the past 52 weeks, KALA has traded between US$0.08 and US$19.77. On Syfe you can trade KALA with $0 commission and add it to your watchlist.
| Previous close | US$0.56 |
|---|---|
| Market cap | US$15.86M |
| 52-week range | US$0.08 – US$19.77 |
| Volume | 81.74K |
| Exchange | US |
Add to Watchlist
Set Price Alert
KALA BIO, Inc.
Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Year: 2017
KALA BIO, Inc. (KALA) stock is trading at US$0.54, -4.53% from the previous close of US$0.56.
The market cap for KALA BIO, Inc. (KALA) stock is approximately US$15.86M.
The 52-week high for KALA BIO, Inc. (KALA) stock is US$19.77.
The 52-week low for KALA BIO, Inc. (KALA) stock is US$0.08.
KALA BIO, Inc. (KALA) does not currently pay a dividend.
Stay on top of KALA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
